HISTORY | PURCHASE | JOIN | STEM CELL ENHANCERS

**This is the ONLY Natural product in the WORLD that Releases MILLIONS More STEM CELLS into Your Bloodstream !**
DIABETES - HIGH BLOOD PREASURE - PARKINSON'S DISEASE - AND ANY
World's First STEM CELL ENHANCER! Release 3 Million NEW STEM CELLS in 90 Minutes!

Stem Cell Treatment Proven To Reduce Parkinson's Symptoms


Parkinson's disease is a brain disorder that occurs when certain nerve cells in the brain die or become damaged. The normal function of these nerve cells is the production of Dopamine - a vital chemical which is responsible for our body's smooth and well-coordinated movement. The lack of Dopamine as a result of damaged nerve cells can cause the Parkinson's symptoms of shaking (tremors), stiffness of the muscles, freeze-ups, balance difficulties and slowness of movement.

In Oct 2006, TiantanPuhuaHospital's groundbreaking treatment introduces 'Human Retinal Pigment Epithelial cells' (hRPE) to patients' bodies causing them to naturally produce Dopamine, enhancing Dopamine levels in the brain. The Hospital's use of hRPE cells means that patients do not have immunosuppressive reactions and therefore do not need to take additional drugs during the treatment. Specifically, the treatment includes a procedure that introduces hRPE cells into the region in the brain where there are damaged cells, along with a daily cocktail of medications that "fertilize" this area, helping the cells to survive.

Tiantan (Temple of Heaven) PuhuaHospital collaborates with the Stem Cells Research Center of China's renowned PekingUniversity, the leading stem cells research group in the country. There, stem cells are nurtured and induced for clinical treatment. To date, over 20 Parkinson's patients have been treated using hRPE stem cells, with all patients exhibiting increased dopamine in their metabolism and improved control of movement. Long-term follow-up of the patients remains unavailable and is currently being carefully researched on a select number of patients. Tiantan Puhua is the only hospital that offers this treatment to patients beyond limited clinical trials and Penny is the only known American citizen treated for Parkinson's using this type of stem cell treatment.

Last July 2002, in USA, Researchers used embryonic stem cells to relieve symptoms of Parkinson's disease in rats, demonstrating the cells can be turned into neurons that make dopamine, a key brain chemical.

The researchers at Harvard Medical School and McLean Hospital in Belmont, Mass., showed in tests that the cells injected into rats whose brains had been chemically damaged would spontaneously convert to correct the Parkinson's symptoms.

Some experts said the study, appearing Tuesday in the Proceedings of the National Academy of Sciences, was significant because it showed embryonic stem cells could be used to treat brain disorders, but they cautioned that the cells also could cause tumors.

In the current study, researchers first developed rats that had Parkinson's disease symptoms by injecting into their brains a toxin that killed neurons.

The researchers then injected embryonic stem cells, extracted from an early mouse embryo and capable of growing into any type of cell.

About nine weeks after the stem cells were in the rat brains, they converted to neurons that make dopamine, a brain chemical lacking in Parkinson's disease patients, Isacson said.

The injected stem cells, said Isacson, grew into the type of neurons that typically die in the brains of Parkinson's patients.

AFA Extract helps increase the number, release from bone marrow & availability of the Adult Stem Cells to the damaged, diseased or dysfunctional tissues of the body. This Stem Cell Enhancers support the natural release of Adult Stem Cells from our own bone marrow. The only stem cell enhancer available is a natural botanical extract. It is a blend of 2 compounds extracted from the cyanophyta Aphanizomenon Flos – aquae (AFA)…blue green algae in Klamath Lake. These compounds are extracted using a proprietary process that utilizes no chemicals, or harsh agents and is highly concentrated in the product.
Other articles and science reports on Adult Stem Cells.
Check, E., Cardiologists take heart from stem-cell treatment success, Nature 428(6986):880, 29 April 2004: "Adult stem cells have long been viewed as less flexible than embryonic stem cells, which can divide to produce any cell type in the body. But recent studies of human cells suggest that adult stem cells can also turn into many cell types, including heart, brain and liver cells."

Terada, N. et al., Bone marrow cells adopt the phenotype of other cells by spontaneous cells fusion, Nature (416(6880):542–545, 4 April 2002.

Cohen, P., Stem cells could save sight, New Scientist 175:(2354):18, 3 August 2002.

Stem cells do their stuff for Parkinson’s patient, New Scientist 174(2338):5, 13 April 2002.

Randerson, J., Stem cells fix the damage, New Scientist 177(2377):14, 11 January 2003.

Pluchino, S. et al., Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis, Nature 422(6933):688–694, 17 April 2003.

Jochen Ringe et al., Stem cells for regenerative medicine: advances in the engineering of tissues and organs, Naturwissenschaften 89(8), August 2002.

About the Formulator of StemEnhance - Christian Drapeau
Mr. Drapeau, a foremost scientist in the study of Aphanizomenon flos-aquae, holds a Masters of Science degree in Neurology and Neurosurgery from the Montreal Neurological Institute, an affiliate of McGill University in Montreal, Quebec, Canada. He has been extensively involved in the study of nutrition, naturopathy, and various natural therapies.

Most significantly, Mr. Drapeau collaborated with many scientists affiliated with Harvard University, McGill University, the University of Illinois, Oregon State University, the University of New Mexico, and the University of Mississippi in the study of the effects of blue-green algae (Aphanizomenon flos-aquae) on human health. Mr. Drapeau continues his involvement in the clinical study of AFA.

Circulating stem cells can reach various organs and become cells of that organ, helping such organ regain and maintain optimal health. Recent studies have suggested that the number of circulating stem cells is a key factor; the higher the number of circulating stem cells the greater is the ability of the body at healing itself. What happens to stem cells if they do not reach a tissue? Stem cells released from the bone marrow that do not reach a tissue simply return to the bone marrow after some time

United States Patent Patent No.: 6,814,961 B1 Date of Patent: November 9, 2004 Subj: METHOD FOR ENHANCING STEM CELL PHYSIOLOGY Inventors: Gitte S. Jensen and Christian Drapeau